Compare Stocks → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:AKUTSE:ONCNASDAQ:PRN Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAKUAkumin$0.18$0.12▼$1.90$26.32M-0.721.38 million shs8.54 million shsONCOncolytics BiotechC$1.44+0.7%C$1.44C$1.20▼C$4.49C$108.61M1.4979,339 shs23,577 shsPRNInvesco Dorsey Wright Industrials Momentum ETF$130.51-0.7%$133.94$90.63▼$142.46$214.04M1.0710,544 shs6,141 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAKUAkumin0.00%0.00%0.00%0.00%-52.67%ONCOncolytics Biotech-0.69%-10.06%+2.88%-11.73%-7.74%PRNInvesco Dorsey Wright Industrials Momentum ETF-0.75%-4.64%-2.42%+12.33%+40.14%Did You Get Your Free Bitcoin Yet? (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right hereMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAKUAkuminN/AN/AN/AN/AN/AN/AN/AN/AONCOncolytics Biotech0.6434 of 5 stars3.50.00.00.01.30.00.0PRNInvesco Dorsey Wright Industrials Momentum ETFN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAKUAkumin1.50Reduce$0.25∞ UpsideONCOncolytics Biotech3.00BuyC$6.00316.67% UpsidePRNInvesco Dorsey Wright Industrials Momentum ETF0.00N/A$132.371.43% UpsideCurrent Analyst RatingsLatest PRN, AKU, ONC, and YGEN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/4/2024ONCOncolytics BiotechRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOutperformC$3.00(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAKUAkumin$749.63M0.00N/AN/A$1.24 per share0.00ONCOncolytics BiotechN/AN/AC$0.34 per share4.22C$0.37 per shareN/APRNInvesco Dorsey Wright Industrials Momentum ETFN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAKUAkumin-$156.76M-$2.52N/AN/AN/A-30.56%-167.86%-7.81%N/AONCOncolytics Biotech-C$27.75M-C$0.41N/A∞N/AN/A-102.66%-55.47%5/3/2024 (Estimated)PRNInvesco Dorsey Wright Industrials Momentum ETFN/AN/A30.27∞N/AN/AN/AN/AN/ALatest PRN, AKU, ONC, and YGEN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/7/2024Q4 2023ONCOncolytics Biotech-C$0.15-C$0.05+C$0.10-C$0.05N/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAKUAkuminN/AN/AN/AN/AN/AONCOncolytics BiotechN/AN/AN/AN/AN/APRNInvesco Dorsey Wright Industrials Momentum ETF$0.480.37%N/AN/AN/ALatest PRN, AKU, ONC, and YGEN DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/15/2024PRNInvesco Dorsey Wright Industrials Momentum ETFQuarterly$0.07273/18/20243/19/20243/22/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAKUAkumin17.020.990.99ONCOncolytics Biotech1.549.018.86PRNInvesco Dorsey Wright Industrials Momentum ETFN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipAKUAkumin36.10%ONCOncolytics Biotech6.98%PRNInvesco Dorsey Wright Industrials Momentum ETFN/AInsider OwnershipCompanyInsider OwnershipAKUAkumin20.51%ONCOncolytics Biotech6.24%PRNInvesco Dorsey Wright Industrials Momentum ETFN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAKUAkumin3,63191.17 million72.47 millionNot OptionableONCOncolytics Biotech2975.42 millionN/ANot OptionablePRNInvesco Dorsey Wright Industrials Momentum ETFN/A1.64 millionN/AOptionablePRN, AKU, ONC, and YGEN HeadlinesSourceHeadlineTop-Ranked ETFs That Outperformed the Market in Q1zacks.com - April 2 at 11:01 AMBuy 5 Top-Ranked ETFs to Play Broadening US Market Rallyzacks.com - March 25 at 2:01 PMShould You Invest in the Invesco Dorsey Wright Industrials Momentum ETF (PRN)?zacks.com - March 20 at 7:21 AM5 Top-Ranked ETFs at New Highs Set to Soar Furtherzacks.com - March 4 at 12:11 PMPRN - Invesco DWA Industrials Momentum ETFfinance.yahoo.com - August 20 at 5:51 PMInvesco DWA Basic Materials Momentum ETF declares quarterly distribution of $0.2133seekingalpha.com - June 21 at 3:02 PMInvesco DWA Industrials Momentum ETF declares quarterly distribution of $0.2963msn.com - December 22 at 6:05 PMPXI: A Good Moment To Buy This Energy Momentum ETFseekingalpha.com - December 19 at 12:40 PMPTF Invesco Exchange-Traded Fund Trust - Invesco DWA Technology Momentum ETFseekingalpha.com - September 20 at 3:52 PMInvesco DWA Industrials Momentum ETF declares quarterly distribution of $0.1191seekingalpha.com - June 21 at 3:51 PMAnalysts Anticipate PRN To Hit $109nasdaq.com - May 9 at 10:13 AMSum Up The Parts: PRN Could Be Worth $117nasdaq.com - March 28 at 8:36 AMAnalyst Ratings For Invescomarkets.businessinsider.com - February 18 at 12:45 PMThe Invesco DWA Industrials Momentum ETF Continues its Poor Performancefinance.yahoo.com - December 15 at 9:44 AM5 Top-Ranked ETFs That Outperformed the Market in Octoberentrepreneur.com - November 3 at 6:34 PMThe Most Common Passive-Aggressive Phrases People Say At Workyahoo.com - October 15 at 6:24 AMShould You Invest in the Invesco DWA Industrials Momentum ETF (PRN)?finance.yahoo.com - August 2 at 9:47 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesCanoo, Inc. Bites the Dust: Mullen Automotive Is a Better BetApril 2, 2024 9:15 AMView Canoo, Inc. Bites the Dust: Mullen Automotive Is a Better BetTesla Stock Drops on Weak Delivery Numbers and it May Fall MoreApril 2, 2024 11:25 AMView Tesla Stock Drops on Weak Delivery Numbers and it May Fall MoreIntel's Foundry Woes: Sell Signal or Silver Lining Ahead?April 5, 2024 8:45 AMView Intel's Foundry Woes: Sell Signal or Silver Lining Ahead?Tesla Is the Analyst's Most Downgraded Stock: How Low Can It Go?March 26, 2024 7:00 AMView Tesla Is the Analyst's Most Downgraded Stock: How Low Can It Go?Cannabis: One Stock to Play the MovementApril 8, 2024 8:38 AMView Cannabis: One Stock to Play the MovementAll Headlines Company DescriptionsAkuminNASDAQ:AKUAkumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to hospitals and health systems across 48 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida.Oncolytics BiotechTSE:ONCOncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and Bavencio, a human anti-PD-L1 antibody for the treatment of hormone receptor-positive/human epidermal growth factor 2-negative metastatic breast cancer. The company was incorporated in 1998 and is headquartered in Calgary, Canada.Invesco Dorsey Wright Industrials Momentum ETFNASDAQ:PRNPowerShares Dynamic Industrials Sector Portfolio (the Fund) seeks investment results that correspond generally to the price and yield of the Dynamic Industrials Sector Intellidex Index (the Index). The Index consists of stocks of 60 United States industrial companies. These are companies that are principally engaged in the business of providing industrial products and services, including engineering, heavy machinery, construction, electrical equipment, aerospace and defense, and general manufacturing. The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.